You are here: Industry Insights > Catalent

News List

Pharmaceutical packaging market to value over $144bn by 2027 europeanpharmaceuticalreview
March 16, 2021
New research suggests the use of innovative and development of eco-friendly packaging, as well as the COVID-19 pandemic will all drive growth in the pharmaceutical packaging market.
Catalent Acquires Delphi Genetics contractpharma
February 24, 2021
Launches US plasmid manufacturing site to establish global pDNA development and manufacturing capabilities.
Catalent, Aurinia Ink LUPKYNIS Commercial Supply Pact contractpharma
February 20, 2021
Catalent has signed a multi-year commercial supply agreement with Aurinia Pharmaceuticals for LUPKYNIS (voclosporin), a drug to treat adult patients with lupus nephritis (LN).
Catalent, Trizell Enter Cell Therapy Deal contractpharma
February 09, 2021
Catalent has signed an agreement with Trizell GmbH, to support the manufacturing of Trizell’s Phase 1 cell therapy for the treatment of micro- and macroangiopathies.
Catalent, Decibel Team Up for Hearing Loss Treatment contractpharma
February 05, 2021
Enter development and manufacturing agreement for dual-vector gene therapy for the treatment of congenital hearing loss.
Catalent Acquires Acorda’s INBRIJA Manufacturing Operations contractpharma
January 14, 2021
The CDMO pays $80 million for dry powder inhaler spray drying, capsule manufacturing and packaging operations in Boston area.
Catalent Divests Blow-Fill-Seal Sterile CDMO Business contractpharma
January 08, 2021
SK Capital Partners, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, has acquired the Blow-Fill-Seal (BFS) sterile contract development and manufacturing business from Catalent Pharma Solutions.
Catalent Appoints Minakuchi Facility GM contractpharma
December 11, 2020
Catalent has appointed Nakaya “Nick” Matsumaru as general manager of its new clinical packaging facility in Minakuchi, located in the Shiga prefecture of Japan.
Passage Bio, Catalent Begin cGMP Mfg. for Gene Therapies contractpharma
December 11, 2020
Completion of dedicated cGMP suite enhances manufacturing readiness and secures supply chain control to support lead CNS product candidates.
Catalent, Blueprint Enter GAVRETO Commercial Supply Pact contractpharma
November 24, 2020
Following FDA approval and tech transfer, the Catalent team in Kansas City will support commercial supply of the non-small cell lung cancer drug.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 13 Next page